Enhancement of radiosensitivity by a unique novel NF-κB inhibitor, DHMEQ, in prostate cancer

BACKGROUND: Inducible activation of nuclear factor (NF)-κB is one of the principal mechanisms through which resistant prostate cancer cells are protected from radiotherapy. We hypothesised that inactivation of inducible NF-κB with a novel NF-κB inhibitor, DHMEQ, would increase the therapeutic effect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kozakai, N, Kikuchi, E, Hasegawa, M, Suzuki, E, Ide, H, Miyajima, A, Horiguchi, Y, Nakashima, J, Umezawa, K, Shigematsu, N, Oya, M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2012
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3419964/
https://ncbi.nlm.nih.gov/pubmed/22805327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.321
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados